GP73 links SARS-CoV-2 infection with dysglycaemia #MMPMID34992300
Coate KC
Nat Metab 2022[Jan]; 4 (1): 9-10 PMID34992300show ga
Severe COVID-19 is often associated with detrimental elevations in blood glucose, but the mechanisms are poorly understood. In this issue of Nature Metabolism, Wan et al. identify GP73 as a SARS-CoV-2-induced secreted factor that enhances hepatic glucose production and is necessary for SARS-CoV-2-associated glucose abnormalities.